Fighting for patient affordability doesn’t necessarily require a scapegoat.
In Search of the ‘Bad Guy’
Related Posts
Agilent Purchases Biovectra for $925 Million
Image Credit: Adobe Stock Images/AD.com In a transaction expected to close by the end of this year, Agilent Technologies Inc., a life sciences organization that […]
Top 3 Podcast Episodes of the Year
This year’s PC Podcast episodes ranged in topic, from DSCSA compliance to pharmacovigilance. With 10 episodes having gone live this year, The Pharmaceutical Podcast featured […]
Getting Pharma Ready for Generation Alpha, Teens Ask Schools to Provide Mental Health Information & more
US Pharma and Biotech Summit 2024: Getting Pharma Ready for Generation Alpha In an interview with Pharm Exec Associate Editor Don Tracy, Carmen Villar, VP, […]